Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Blend · Wasatch

Wasatch U.S. Select Fund Investor Class (WAUSX)

Ticker WAUSX · Since 2022-06-13 · · Holdings as of Jun 30, 2026

Expense ratio
1.01%$101/yr per $10k
1-yr return
−4.5%as of Dec 2025
Net assets
$17.1Mall share classes
Holdings
34

Bottom line

Is WAUSX a good fund? The bottom line

WAUSX is the Investor Class share class of Wasatch U.S. Select Fund, an actively managed large blend mutual fund from Wasatch.

It charges 1.01% — about $101 a year on every $10,000 invested, more expensive than 64% of large blend funds we track.

It returned −4.5% over one year (as of Dec 31, 2025, per its prospectus).

With $17.1 million in net assets and 34 holdings, its largest position is HealthEquity Inc (6.2%) and the top 10 make up 41.4% of the portfolio.

What stands out

  • No front-end sales load

What to watch

  • Small fund ($17.1 million) — small funds are likelier to close

Updated Nov 19, 2026

What WAUSX invests in

The Funds investment objective is long-term growth of capital.

The Fund invests primarily in domestic companies of all market capitalizations. Under normal market conditions, we will invest at least 80% of the Funds net assets (plus borrowings for investment purposes) in equity securities of companies of all market capitalizations that are tied economically to the U.S. Equity securities include common stock. We will consider qualifying investments to be in companies that are listed on a U.S. exchange, that have at least 50% of their assets in the U.S., or that, during the issuers most recent fiscal year, derived at least 50% of its revenues or profits from goods produced or sold, investments made, or services performed in the U.S. As the Fund may invest in companies of any size, we expect to invest the Funds assets across a broad market capitalization range, from micro-capitalization stocks to larger capitalization stocks. However, we may invest a…

From the fund's prospectus (filed Jan 28, 2026).

WAUSX performance

Fund calendar-year total returns, 2023–2025 2023: +33.4%; 2024: +9.2%; 2025: −4.5% +33.4% 2023 +9.2% 2024 −4.5% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
WAUSX−4.5%——
Large Blend median+13.8%+9.7%+10.9%

Source: Fund prospectus, as of Dec 31, 2025

Full WAUSX performance history →

What WAUSX costs

On a $10,000 investment, WAUSX's 1.01% expense ratio costs about $101 a year. The prospectus estimates $1,860 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.

See the full WAUSX fee table →

WAUSX top 10 holdings

#Holding% of fund
1HealthEquity Inc6.20%
2SharkNinja Inc4.90%
3AMETEK Inc4.02%
4UL Solutions Inc3.96%
5AAON Inc3.88%
6HEICO Corp3.85%
7West Pharmaceutical Services Inc3.66%
8PJT Partners Inc3.65%
9RBC Bearings Inc3.64%
10Novanta Inc3.61%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 41.4% of the fund. See all top 25 holdings and asset mix →

Alternatives to WAUSX

More funds like WAUSX →

WAUSX FAQ

What is the expense ratio of WAUSX?
WAUSX's expense ratio is 1.01%, which works out to about $101 a year for every $10,000 invested. The prospectus estimates total costs of $1,860 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is WAUSX a good investment?
It depends on your goals, but the data points to: no front-end sales load; small fund ($17.1 million) — small funds are likelier to close. This is general information, not personalized advice.
What does WAUSX hold?
WAUSX's largest holdings are HealthEquity Inc (6.2%), SharkNinja Inc (4.9%), AMETEK Inc (4.0%), UL Solutions Inc (4.0%), AAON Inc (3.9%). It holds 34 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
Does WAUSX have a sales load?
No. WAUSX has no front-end sales charge.
Who manages WAUSX?
WAUSX is offered by Wasatch through Wasatch Funds Trust.